
Regulators around the world should be prepared for this by adapting to a pooled network of biomarkers to approve vaccines, the organisation said in a note on the future of Covid-19 vaccines.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2LpTapp
via
IFTTT
0 comments:
Post a Comment